MicrobiologybioRxiv
High-dose rifamycins enable shorter oral treatment in a murine model of Mycobacterium ulcerans disease
T. F. Omansen, D. Almeida, P. J. Converse…·E. Nuermberger
This study evaluates higher doses of rifamycins in a mouse model of Buruli ulcer, finding dose-dependent efficacy and potential for shorter treatment regimens.
DOI 10.1128/aac.01478-18